Previous Close | 6.19 |
Open | 6.16 |
Bid | 6.02 x 800 |
Ask | 6.03 x 2900 |
Day's Range | 5.89 - 6.16 |
52 Week Range | 3.49 - 10.39 |
Volume | |
Avg. Volume | 348,703 |
Market Cap | 237.745M |
Beta (5Y Monthly) | 2.27 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.66 |
Earnings Date | Nov 01, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 12.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for APEN
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of -23.81% and 7.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the second quarter ended June 30, 2022 and recent corporate highlights.